Literature DB >> 17656761

Whole-mount immunoelectron tomography of chromosomes and cells.

Peter Engelhardt1, Jari Meriläinen, Fang Zhao, Susumu Uchiyama, Kiichi Fukui, Veli-Pekka Lehto.   

Abstract

Standard immunogold-labeling methods in transmission electron microscopy (TEM) are unable to locate immunogold particles in the depth direction. This inability does not only concern bulky whole mounts, but also sections. A partial solution to the problem is stereo inspection. However, three-dimensional reconstruction of immunogold-labeled structures, that is, immuno-electron tomography (IET), is a correct solution for this inconsistency. Striking improvement in resolution is achieved: the 1.4-nm immunogold particles are shown in IET that are not detected in the original tilt series. IET is not restricted to laboratories with advanced medium- or high-voltage TEM and super-computing facilities; the methods we have developed for whole-mounted chromosomes and also for whole-mounted cytoskeleton of fibroblasts work remarkably well with ordinary 80-kV TEMs equipped with a goniometer to collect tilt series for IET on film. In addition, free programs are available to produce three-dimensional reconstructions even without high-performance computers. These improvements make it possible to many laboratories without modern facilities to perform IET reconstruction with standard TEM apparatus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656761     DOI: 10.1007/978-1-59745-294-6_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  1 in total

1.  Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy.

Authors:  Markus Vähä-Koskela; Siri Tähtinen; Susanna Grönberg-Vähä-Koskela; Kristian Taipale; Dipongkor Saha; Maiju Merisalo-Soikkeli; Marko Ahonen; Noora Rouvinen-Lagerström; Mari Hirvinen; Ville Veckman; Sampsa Matikainen; Fang Zhao; Päivi Pakarinen; Jarmo Salo; Anna Kanerva; Vincenzo Cerullo; Akseli Hemminki
Journal:  Mol Ther Oncolytics       Date:  2015-01-07       Impact factor: 7.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.